Kura Oncology (KURA) Accumulated Depreciation (2014 - 2026)

Kura Oncology (KURA) has 13 years of Accumulated Depreciation data on file, last reported at $3.2 million in Q1 2026.

• On a quarterly basis, Accumulated Depreciation fell 7.82% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 7.82% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, down 11.45% from the prior year.
• Accumulated Depreciation for Q1 2026 stood at $3.2 million, up from $2.9 million in the prior quarter.
• Over the last five years, Accumulated Depreciation for KURA reached as high as $3.9 million in Q3 2025 and fell as low as $1.0 million in Q1 2022.
• Historically, Accumulated Depreciation has averaged $2.5 million across 5 years, with a median of $2.7 million in 2024.
• Across the five-year window, Accumulated Depreciation surged 159.14% in 2022 and slipped 11.45% in 2025, its largest moves.
• Year by year, Accumulated Depreciation stood at $1.6 million in 2022, then surged by 52.96% to $2.5 million in 2023, then surged by 33.56% to $3.3 million in 2024, then fell by 11.45% to $2.9 million in 2025, then gained by 11.76% to $3.2 million in 2026.
• Per Business Quant data, the three most recent Accumulated Depreciation figures were $3.2 million in Q1 2026, $2.9 million in Q4 2025, and $3.9 million in Q3 2025.